/Germany Approves First Trial of COVID-19 Vaccine Candidate

Germany Approves First Trial of COVID-19 Vaccine Candidate

Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.